MedTrace Logo

A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine

NCT02147561 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 280

Last updated 2016-05-27

Study results available
· View outcomes & findings →

Summary

This study will evaluate the safety and efficacy of BOTOX® treatment in Korean adults with chronic migraine.

Conditions

  • Migraine Disorders

Interventions

BIOLOGICAL

botulinum toxin Type A

Botulinum toxin Type A injected across specific head and neck muscles on Day 0.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02147561 on ClinicalTrials.gov